There are devastating conditions that currently offer very few options for families. This is what science has planned.

NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a focus on pipeline ...

Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic ...

In 2025, Seres received a non-dilutive award from CARB-X for up to $3.6 million, representing the Company’s second CARB-X award, to support development of an oral liquid formulation based on SER-155 ...

Good day, and welcome to the WD-40 Company Second Quarter Fiscal Year 2026 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] I would now like to turn the presentation ...

Pure Cycle Corporation (NASDAQ Capital Market: PCYO) ("Pure Cycle", "we", "us" or "our") announced its financial results for the three and six months ended ...

Net loss attributable to NovaBridge was $46.3 million for the year ended December 31, 2025, compared to $22.2 million for the year ended December 31, 2024. Net loss per share attributable to ordinary ...

ClearSign Technologies Corporation (NASDAQ:CLIR) Q4 2025 Earnings Call Transcript April 9, 2026 ClearSign Technologies Corporation beats earnings expectations. Reported EPS is $0.01, expectations were ...

WD-40 Company (NASDAQ:WDFC) Q2 2026 Earnings Call Transcript April 9, 2026 WD-40 Company beats earnings expectations. Reported EPS is $1.5, expectations were $1.39. Operator: Ladies and gentlemen, ...